Researchers at the University of York have developed a new way to safely remove a blood-thinning drug used during surgery that can lead to harmful side-effects in recovering patients.
Jul 4, 2019
0
2
Remyelination is a critical repair process in demyelinating diseases such as multiple sclerosis (MS). Chondroitin sulfate proteoglycans (CSPGs), a family of large molecules consisting of a core protein and glycosaminoglycans ...
Dec 8, 2017
0
1
(HealthDay)—There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study ...
Aug 6, 2013
0
0
